Brand name, generic drugs battle for market share

Brand name drug prices dropping but pharmacies, not employers, will likely reap benefits

The battle for market share between generic and brand name drug manufacturers is expected to heat up as the patents for several brand name drugs expire next year, but employers aren’t expected to reap the benefits.

To read the full story, login below.

Not a subscriber?

Start your subscription today!